Chapter 95. Acute Leukemia
Which of the following prognostic factors in AML is associated with the highest risk of relapse?
D. Minimal residual disease
Which of the following agents is most frequently used as prophylaxis for the prevention of fungal infections in AML?
Which of the two agents are most frequently used for the treatment of induction therapy in AML?
A. Vincristine and asparaginase
B. Doxorubicin and cyclophosphamide
C. Cytarabine and daunorubicin
D. Methotrexate and vincristine
The single strongest prognostic factor in ALL is:
C. Presence of central nervous system leukemia (CNS3)
D. Early treatment response as assessed by minimal residual disease(MRD) at end of induction
The ALL treatment modality that is most associated with later development of secondary acute myeloid leukemia with balanced translocations is:
B. High dose methotrexate
Which of the following features excludes a diagnosis of B-cell precursor ALL?
A. Presence of T-cell receptor gene rearrangements
C. WBC count > 500,000/microliter
D. Expression of cytoplasmic CD3
Which of the following translocation is seen in Philadelphia chromosome positive (Ph+ pre B-cell ALL) ?
Which of the following prognostic factors is most likely associated with the risk of relapse induction therapy for acute lymphocytic ...